Tata Nifty MidSmall Healthcare Index Fund
Tata Nifty MidSmall Healthcare Index Fund portfolio holdings, Oct 2026: 30 stocks, ₹241 cr in listed equity, from Tata Mutual Fund's monthly disclosure; changes by share count against Sep 2026.
Fund managers: Nitin Sharma; Rakesh Prajapati
Benchmark: Nifty MidSmall Healthcare Index (TRI) · Riskometer: Very High · SEBI category, as filed: Index Fund ·
Source: AMFI scheme summary document
Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Option
Source: AMFI
The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.
Category median: direct 0.39 %, regular 0.93 % (284 schemes) · Regular costs ₹560 more a year per ₹1 lakh
Of this, the base expense ratio, the part SEBI caps: direct 0.37 %, regular 0.90 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.
A year, as of 21 Nov 2026. Source: AMFI · Glossary: TER
30 stocks, Oct 2026.
As the AMC's file prints % of NAV. The top 10 stocks together: 60.1%.
This month: Oct 2026
compared with Sep 2026 · by share countMoves, Oct 2026
How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.
- New0
- Added30
- Trimmed0
- Exited0
Asset mix, Oct 2026
How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.
- Listed equity100.2%
- Rest, not itemised0.0%
Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.
Sectors and top 10, Oct 2026
Sector mix, Oct 2026
How the scheme's equity is spread across sectors at month end.
- 100.0%
AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.
Large, mid and small cap, Oct 2026
How the scheme's equity splits across large, mid and small companies, on AMFI's list.
- Mid Cap68.1%
- Small Cap31.9%
AMFI's list of Jun 2026.
Top 10 holdings
Its ten largest stocks, each as a share of the fund.
- 14.12%
- 7.36%
- 7.00%
- 6.03%
- 5.22%
- 4.65%
- 4.26%
- 4.04%
- 3.72%
- 3.70%
As the AMC's file prints % of NAV.
| Stock | Change | Shares before | Shares now | Difference | Change % | Value of change | Value now |
|---|---|---|---|---|---|---|---|
| LAURUSLABS | Added | 1.32 lakh | 1.41 lakh | +9,458 | +7.2% | +₹2.3 cr | ₹34.0 cr |
| LUPIN | Added | 82,281 | 88,180 | +5,899 | +7.2% | +₹1.2 cr | ₹17.7 cr |
| AUROPHARMA | Added | 93,615 | 1.00 lakh | +6,711 | +7.2% | +₹1.1 cr | ₹16.9 cr |
| FORTIS | Added | 1.76 lakh | 1.89 lakh | +12,654 | +7.2% | +₹0.97 cr | ₹14.5 cr |
| GLENMARK | Added | 51,001 | 54,657 | +3,656 | +7.2% | +₹0.84 cr | ₹12.6 cr |
| ALKEM | Added | 20,425 | 21,890 | +1,465 | +7.2% | +₹0.75 cr | ₹11.2 cr |
| MANKIND | Added | 38,387 | 41,139 | +2,752 | +7.2% | +₹0.69 cr | ₹10.3 cr |
| IPCALAB | Added | 47,059 | 50,433 | +3,374 | +7.2% | +₹0.65 cr | ₹9.7 cr |
| GLAND | Added | 26,996 | 28,931 | +1,935 | +7.2% | +₹0.60 cr | ₹9.0 cr |
| BIOCON | Added | 2.36 lakh | 2.53 lakh | +16,925 | +7.2% | +₹0.60 cr | ₹8.9 cr |
| SAILIFE | Added | 46,851 | 50,210 | +3,359 | +7.2% | +₹0.52 cr | ₹7.8 cr |
| ACUTAAS | Added | 17,578 | 18,838 | +1,260 | +7.2% | +₹0.50 cr | ₹7.5 cr |
| KIMS | Added | 90,397 | 96,877 | +6,480 | +7.2% | +₹0.45 cr | ₹6.8 cr |
| ASTERDM | Added | 90,546 | 97,038 | +6,492 | +7.2% | +₹0.44 cr | ₹6.6 cr |
| NEULANDLAB | Added | 2,921 | 3,131 | +210 | +7.2% | +₹0.41 cr | ₹6.2 cr |
| AJANTPHARM | Added | 15,443 | 16,550 | +1,107 | +7.2% | +₹0.39 cr | ₹5.8 cr |
| WOCKPHARMA | Added | 27,982 | 29,988 | +2,006 | +7.2% | +₹0.38 cr | ₹5.7 cr |
| LALPATHLAB | Added | 26,429 | 28,324 | +1,895 | +7.2% | +₹0.36 cr | ₹5.4 cr |
| PPLPHARMA | Added | 2.10 lakh | 2.26 lakh | +15,085 | +7.2% | +₹0.36 cr | ₹5.4 cr |
| ABBOTINDIA | Added | 1,765 | 1,891 | +126 | +7.1% | +₹0.32 cr | ₹4.8 cr |
| GRANULES | Added | 49,956 | 53,538 | +3,582 | +7.2% | +₹0.30 cr | ₹4.5 cr |
| ONESOURCE | Added | 26,663 | 28,574 | +1,911 | +7.2% | +₹0.30 cr | ₹4.5 cr |
| NH | Added | 23,401 | 25,079 | +1,678 | +7.2% | +₹0.29 cr | ₹4.3 cr |
| MEDANTA | Added | 30,022 | 32,174 | +2,152 | +7.2% | +₹0.27 cr | ₹4.1 cr |
| GLAXO | Added | 14,024 | 15,029 | +1,005 | +7.2% | +₹0.25 cr | ₹3.7 cr |
| ANTHEM | Added | 36,551 | 39,172 | +2,621 | +7.2% | +₹0.22 cr | ₹3.2 cr |
| NATCOPHARM | Added | 30,435 | 35,724 | +5,289 | +17.4% | +₹0.41 cr | ₹2.8 cr |
| SYNGENE | Added | 64,320 | 68,932 | +4,612 | +7.2% | +₹0.19 cr | ₹2.8 cr |
| COHANCE | Added | 55,110 | 59,062 | +3,952 | +7.2% | +₹0.18 cr | ₹2.6 cr |
| POLYMED | Added | 12,934 | 13,861 | +927 | +7.2% | +₹0.13 cr | ₹2.0 cr |
Value of change = the difference in shares × this month's price in the AMC's file. Value now = the whole holding's market value in that file (an exit: last month's).
Show all 30 stocksShow the first 15
Equity rows as disclosed, Oct 2026. Source: Tata Mutual Fund monthly portfolio. Report a wrong number
Large, mid and small caps, % of net assets, last 12 months
AMFI list in force each month
| Month | Large | Mid | Small | Not in AMFI's list | AMFI list |
|---|---|---|---|---|---|
| Oct 2026 | 0.0% | 68.2% | 32.0% | 0.0% | Jun 2026 |
| Sep 2026 | 0.0% | 67.9% | 32.2% | 0.0% | Jun 2026 |
| Aug 2026 | 0.0% | 67.6% | 32.5% | 0.0% | Jun 2026 |
| Jul 2026 | 0.0% | 68.3% | 31.7% | 0.0% | Jun 2026 |
| Jun 2026 | 0.0% | 64.6% | 35.4% | 0.0% | Dec 2025 |
| May 2026 | 0.0% | 64.5% | 35.6% | 0.0% | Dec 2025 |
| Apr 2026 | 0.0% | 65.5% | 34.6% | 0.0% | Dec 2025 |
| Mar 2026 | 0.0% | 66.3% | 33.6% | 0.0% | Dec 2025 |
| Feb 2026 | 0.0% | 68.5% | 32.9% | 0.0% | Dec 2025 |
| Jan 2026 | 0.0% | 67.0% | 33.0% | 0.0% | Dec 2025 |
| Dec 2025 | 14.1% | 53.6% | 32.3% | 0.0% | Jun 2025 |
| Nov 2025 | 14.1% | 53.6% | 32.3% | 0.0% | Jun 2025 |
Equity holdings' % of net assets each month, by AMFI's cap list in force that month.
Portfolio turnover, from holdings
equity only · month-end snapshots
| Month | Bought | Sold | Turnover |
|---|---|---|---|
| Oct 2026 | ₹16.4 cr | ₹0.00 cr | 0.0% |
| Sep 2026 | ₹10.0 cr | ₹1.9 cr | 0.9% |
| Aug 2026 | ₹9.2 cr | ₹0.00 cr | 0.0% |
| Jul 2026 | ₹24.0 cr | ₹5.4 cr | 2.8% |
| Jun 2026 | ₹0.33 cr | ₹0.00 cr | 0.0% |
| May 2026 | ₹0.00 cr | ₹0.74 cr | 0.0% |
| Apr 2026 | ₹0.00 cr | ₹0.39 cr | 0.0% |
| Mar 2026 | ₹4.2 cr | ₹4.3 cr | 2.7% |
| Feb 2026 | ₹2.2 cr | ₹0.00 cr | 0.0% |
| Jan 2026 | ₹0.00 cr | ₹0.73 cr | 0.0% |
| Dec 2025 | ₹0.79 cr | ₹2.0 cr | 0.5% |
| Nov 2025 | ₹0.63 cr | ₹0.00 cr | 0.0% |
The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.
| Period | Direct plan | Regular plan | Benchmark, as published by AMFI Nifty MidSmall Healthcare TRI |
|---|---|---|---|
| 1 year | +22.48 % | +21.76 % | +23.14 % |
| Since launch | +19.59 % | +18.83 % | +20.46 % |
Past performance may not be sustained in future.
As AMFI's fund performance report prints them for "Tata Nifty MidSmall Healthcare Index Fund"; this site computes no benchmark figure of its own.
How it is computed: NAV to NAV
Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Option: these run to the newest NAV stored (20 Nov 2026) and are computed here from AMFI's NAV files; AMFI's figures above run to 19 Nov 2026, so the two differ by the days in between.
| Period | Return | From | To |
|---|---|---|---|
| 1 year | +23.35 % in total | 20 Nov 2025 · NAV ₹12.9230 | 20 Nov 2026 · NAV ₹15.9406 |
| Since first NAV | +19.60 % a year, compounded | 30 Apr 2024 · NAV ₹10.0831 | 20 Nov 2026 · NAV ₹15.9406 |
Source: AMFI NAV files (plan code 152564). How to read Report a wrong number
Tracking error and tracking difference
index fund / ETF · as published by AMFI
| Tracking difference, Oct 2026 | Direct plan | Regular plan |
|---|---|---|
| 1 year | −0.63 % | −1.34 % |
| Since launch | −0.86 % | −1.62 % |
As AMFI publishes them against Nifty MidSmall Healthcare TRI. Source: AMFI tracking error and tracking difference. How to read
IDCW (dividend) history
0 declarations · as of 3 Nov 2026 · Source: AMFI
IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.
Rolling returns, Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Option
weekly NAVs · Source: AMFI
| Window | Lowest | Median | Highest | Windows above zero |
|---|---|---|---|---|
| 1 year in total | −1.91 % 3 Jan 2025 to 9 Jan 2026 | +13.40 % 9 Aug 2024 to 14 Aug 2025 | +25.38 % 31 May 2024 to 6 Jun 2025 | 99 % of 81 windows ending 9 May 2025 to 20 Nov 2026 |
Past performance may not be sustained in future.
Every 1-, 3- and 5-year window ending on a week's last NAV, lowest, middle and highest.
Standard deviation of weekly NAV changes × √52. 3 May 2024 to 20 Nov 2026, 133 weekly changes.
Source: AMFI
High 3 Jan 2025, low 28 Feb 2025; back at the high 18 Jul 2025.
Weekly NAVs since 3 May 2024. Measured on each week's last NAV, so a fall within a week can be deeper than shown.
Source: AMFI
Past performance may not be sustained in future.
Highest and lowest of 248 daily NAVs, 20 Nov 2025 to 20 Nov 2026, Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Option.
Source: AMFI
Calendar-year returns, Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Option
NAV to NAV · Source: AMFI
| Year | Return | From | To |
|---|---|---|---|
| 2025 | −0.92 % | 31 Dec 2024 · NAV ₹13.0152 | 31 Dec 2025 · NAV ₹12.8957 |
Past performance may not be sustained in future.
Change in the plan's NAV over each calendar year, last NAV to last NAV. Source: AMFI NAV files. How to read
Monthly SIP of ₹10,000, Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Option
XIRR · Source: AMFI
| Period | Instalments | Paid in | Value | XIRR, a year |
|---|---|---|---|---|
| 1 year 1 Dec 2025 to 2 Nov 2026 | 12 | ₹1,20,000 | ₹1,39,340 20 Nov 2026 · NAV ₹15.9406 | +33.13 % |
Past performance may not be sustained in future.
₹10,000 on the first NAV of each month, valued at the newest NAV; no stamp duty, exit load or tax taken off.
Embed this card
Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.
- 3 Nov 2026 · TER change: Tata Nifty MidSmall Healthcare Index Fund: AMFI TER file of 3 Nov 2026: direct plan 0.59% (was 0.58%); regular plan 1.15% (was 1.14%); previous file 31 Oct 2026
- 4 Oct 2026 · TER change: Tata Nifty MidSmall Healthcare Index Fund: AMFI TER file of 4 Oct 2026: direct plan 0.58% (was 0.56%); regular plan 1.14% (was 1.12%); previous file 29 Sep 2026
From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.
Questions about Tata Nifty MidSmall Healthcare Index Fund
from the figures on this pageWhat are the top holdings of Tata Nifty MidSmall Healthcare Index Fund?
At Oct 2026 end, Tata Nifty MidSmall Healthcare Index Fund held 30 stocks (100.2% of the fund in equity). Largest: Laurus Labs 14.12%, Lupin 7.36%, Aurobindo Pharma 7.00%, Fortis Healthcare 6.03%, Glenmark Pharmaceuticals 5.22%; the top 10 make up 60.1%. Funds holding Laurus Labs · Funds holding Lupin · Funds holding Aurobindo Pharma
What portfolio changes did Tata Nifty MidSmall Healthcare Index Fund make in Oct 2026?
Compared with Sep 2026, by share count: 0 new, 30 added, 0 trimmed, 0 exited. Largest by value: Laurus Labs (added), Lupin (added), Aurobindo Pharma (added), Fortis Healthcare (added).
Who manages Tata Nifty MidSmall Healthcare Index Fund?
AMFI's scheme summary document names Nitin Sharma, Rakesh Prajapati for Tata Nifty MidSmall Healthcare Index Fund (Tata Mutual Fund). Nitin Sharma, fund manager portfolio · Rakesh Prajapati, fund manager portfolio
All schemes of Tata Mutual Fund →
Mutual fund investments are subject to market risks; read all scheme related documents carefully.